Brucella abortus invasion of osteoblasts inhibits bone formation

Infection and Immunity

Volumn 80, Issue 7, 2012, Pages 2333-2345

  Scian, Romina ^a,b   Barrionuevo, Paula ^a,b   Fossati, Carlos A ^a   Giambartolomei, Guillermo H ^a,b   Delpino, M Victoria ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BRUCELLA ABORTUS; BRUCELLOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; MACROPHAGE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; BRUCELLA ABORTUS; CELLS, CULTURED; MACROPHAGES; MICE; OSTEOBLASTS; OSTEOGENESIS;

EID: 84864820696     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00208-12     Document Type: Article

References (57)

1. Aydin M, et al. 2005. Scintigraphic findings in osteoarticular brucellosis. Nucl. Med. Commun. 26:639-647.
2. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. 2000. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275:4858-4864.
3. Baker PJ, et al. 1999. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67:2804 -2809.
4. Bellows CG, Aubin JE, Heersche JN. 1991. Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner. 14:27- 40.
5. Boyce BF, et al. 2005. TNF-alpha and pathologic bone resorption. Keio J. Med. 54:127-131.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248 -254.
7. Buckwalter JA, Cooper RR. 1987. Bone structure and function. Instr. Course Lect. 36:27- 48.
8. Caron E, Gross A, Liautard JP, Dornand J. 1996. Brucella species release a specific, protease-sensitive, inhibitor of TNF-alpha expression, active on human macrophage-like cells. J. Immunol. 156:2885-2893.
9. Chen G, Goeddel DV. 2002. TNF-R1 signaling: a beautiful pathway. Science 296:1634 -1635.
10. Claro T, et al. 2011. Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS One 6:e18748. doi:10.1371/journal.pone.0018748.
11. Colmenero JD, et al. 2008. Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin. Infect. Dis. 46:426- 433.
12. Delpino MV, et al. 2012. Macrophage-elicited osteoclastogenesis in response to Brucella abortus infection requires TLR2/MyD88-dependent TNF-alpha production. J. Leukoc. Biol. 91:285-298.
13. Delpino MV, Barrionuevo P, Scian R, Fossati CA, Baldi PC. 2010. Brucella-infected hepatocytes mediate potentially tissue-damaging immune responses. J. Hepatol. 53:145-154.
14. Delpino MV, Fossati CA, Baldi PC. 2009. Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp. Infect. Immun. 77:984 -995.
15. Garcia Samartino C, et al. 2010. Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis. Am. J. Pathol. 176:1323-1338.
16. Goto H, et al. 2011. Primary human bone marrow adipocytes support TNF-alpha-induced osteoclast differentiation and function through RANKL expression. Cytokine 56:662- 668.
17. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493-2500.
18. Hill PA. 1998. Bone remodelling. Br. J. Orthod. 25:101-107.
19. Hobbie S, Chen LM, Davis RJ, Galan JE. 1997. Involvement of mitogenactivated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J. Immunol. 159:5550 -5559.
20. Hughes DE, Boyce BF. 1997. Apoptosis in bone physiology and disease. Mol. Pathol. 50:132-137.
21. Jeng GW, et al. 1997. Measurement of synovial tumor necrosis factoralpha in diagnosing emergency patients with bacterial arthritis. Am. J. Emerg. Med. 15:626-629.
22. Kerwin SC, et al. 1992. Diskospondylitis associated with Brucella canis infection in dogs: 14 cases (1980 -1991). J. Am. Vet. Med. Assoc. 201: 1253-1257.
23. Kim CH, et al. 2002. IL-1beta regulates cellular proliferation, prostaglandin E2 synthesis, plasminogen activator activity, osteocalcin production, and bone resorptive activity of the mouse calvarial bone cells. Immunopharmacol. Immunotoxicol. 24:395- 407.
24. Kong YY, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304 -309.
25. Krens SF, Spaink HP, Snaar-Jagalska BE. 2006. Functions of the MAPK family in vertebrate-development. FEBS Lett. 580:4984-4990.
26. Kunes P, et al. 2009. Neutrophil apoptosis by Fas/FasL: harmful or advantageous in cardiac surgery? Thorac. Cardiovasc. Surg. 57:1- 6.
27. Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM. 2003. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170:6244- 6249.
28. Landis WJ. 1995. The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix. Bone 16:533-544.
29. Lawrence MC, et al. 2008. The roles of MAPKs in disease. Cell Res. 18:436-442.
30. Lee CW, et al. 2007. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/ p300 binding in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L799 -L812.
31. Li W, et al. 2010. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha. Biochem. Biophys. Res. Commun. 391:1228 -1233.
32. Lyons E, Magnani D, Forde Toni S, Splitter G, Adarichev Vyacheslav A. 2011. Brucellosis-induced murine arthritis and spondylolisthesis. Arthritis Rheum. 63(Suppl 10):2096.
33. Madkour MM. 2001. Bone and joint imaging, p 90-132. In MadkourMM (ed), Madkour's brucellosis, 2nd ed. Springer-Verlag, Berlin, Germany.
34. Madkour MM. 2001. Osteoarticular brucellosis, p 74-87. In Madkour MM (ed), Madkour's brucellosis, 2nd ed. Springer-Verlag, Berlin, Germany.
35. Murphy CM, Haugh MG, O'Brien FJ. 2010. The effect of mean pore size on cell attachment, proliferation and migration in collagenglycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 31: 461-466.
36. Ning RD, Zhang XL, Li QT, Guo XK. 2011. The effect of Staphylococcus aureus on apoptosis of cultured human osteoblasts. Orthop. Surg. 3:199-204.
37. Panagakos FS, Kumar S. 1994. Modulation of proteases and their inhibitors in immortal human osteoblast-like cells by tumor necrosis factoralpha in vitro. Inflammation 18:243-265.
38. Plunkett NA, Partap S, O'Brien FJ. 2010. Osteoblast response to rest periods during bioreactor culture of collagen-glycosaminoglycan scaffolds. Tissue Eng. Part A 16:943-951.
39. Rajapakse CN. 1995. Bacterial infections: osteoarticular brucellosis. Baillieres Clin. Rheumatol. 9:161-177.
40. Redlich K, et al. 2002. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 46:785-792.
41. Sasano Y, et al. 2000. Immunohistochemical localization of type I collagen, fibronectin and tenascin C during embryonic osteogenesis in the dentary of mandibles and tibias in rats. Histochem. J. 32:591-598.
42. Scian R, et al. 2011. Granulocyte-macrophage colony-stimulating factorand tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus. Infect. Immun. 79:192-202.
43. Smeak DD, Olmstead ML, Hohn RB. 1987. Brucella canis osteomyelitis in two dogs with total hip replacements. J. Am. Vet. Med. Assoc. 191:986- 990.
44. Smith MD, et al. 1992. Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 24:19 -26.
45. Somayaji SN, Ritchie S, Sahraei M, Marriott I, Hudson MC. 2008. Staphylococcus aureus induces expression of receptor activator of NFkappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect. Immun. 76:5120 -5126.
46. Takayanagi H. 2010. The unexpected link between osteoclasts and the immune system. Adv. Exp. Med. Biol. 658:61- 68.
47. Tang P, Rosenshine I, Cossart P, Finlay BB. 1996. Listeriolysin O activates mitogen-activated protein kinase in eucaryotic cells. Infect. Immun. 64:2359 -2361.
48. Tang P, Sutherland CL, Gold MR, Finlay BB. 1998. Listeria monocyto-genes invasion of epithelial cells requires the MEK-1/ERK-2 mitogenactivated protein kinase pathway. Infect. Immun. 66:1106 -1112.
49. Tang Y, et al. 2011. Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. J. Endod. 37:1653-1658.
50. Thammasitboon K, Goldring SR, Boch JA. 2006. Role of macrophages in LPS-induced osteoblast and PDL cell apoptosis. Bone 38:845- 852.
51. Tierney CM, Jaasma MJ, O'Brien FJ. 2009. Osteoblast activity on collagen-GAG scaffolds is affected by collagen and GAG concentrations. J. Biomed. Mater. Res. A 91:92-101.
52. Tullberg-Reinert H, Jundt G. 1999. In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem. Cell Biol. 112:271-276.
53. Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T. 2002. The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res. 4:281-289.
54. Wong GL, Cohn DV. 1975. Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc. Natl. Acad. Sci. U. S. A. 72:3167-3171.
55. Wu L, Lin JH, Bao K, Li PF, Zhang WG. 2009. In vitro effects of erythromycin on RANKL and nuclear factor-kappa B by human TNFalpha stimulated Jurkat cells. Int. Immunopharmacol. 9:1105-1109.
56. Yamashita N, et al. 2000. Induction of apoptosis in bronchial eosinophils: beneficial or harmful? Int. Arch. Allergy Immunol. 122(Suppl 1):40 - 43.
57. Young EJ. 1989. Clinical manifestations of human brucellosis. In Young EJ, Corbel MJ, (ed) Brucellosis: clinical and laboratory aspects. CRC Press, Boca Raton, FL.